acetylmuramyl-alanyl-isoglutamine

Preferred Label : acetylmuramyl-alanyl-isoglutamine;

MeSH definition : Peptidoglycan immunoadjuvant originally isolated from bacterial cell wall fragments; also acts as pyrogen and may cause arthritis; stimulates both humoral and cellular immunity.;

MeSH synonym : isoglutamine, acetylmuramyl alanyl; muramyl dipeptide; alanyl isoglutamine, acetylmuramyl; dipeptide, muramyl; acetylmuramyl alanyl isoglutamine;

MeSH hyponym : n-acetylmuramyl-l-alanyl-d-isoglutamine; Mur-NAc-L-Ala-D-isoGln; Mur NAc L Ala D isoGln; N Acetylmuramyl L Alanyl D Isoglutamine; N-Acetyl-Muramyl-L-Alanyl-D-Glutamic-alpha-Amide; N Acetyl Muramyl L Alanyl D Glutamic alpha Amide;

MeSH CAS label : D-alpha-Glutamine, N2-(N-(N-acetylmuramoyl)-L-alanyl)-;

Registry Number MeSH : 53678-77-6;

MeSH annotation : /biosyn permitted; DF: AMAIG;

Codes EINECS : 258-696-9;

Is substance : O;

Details

Origin ID

D000119;

UMLS CUI

C0001060;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Muramyl Dipeptide [NCIt concept]
CISMeF manual mappings
- acetylmuramyl-alanyl-isoglutamine [Substance BNPC]
Indexing information
- MIS416 vaccine [MeSH Supplementary Concept]
Pharmacological action(s)
- adjuvants, immunologic [MeSH Descriptor]
Record concept(s)
- Acetylmuramyl-Alanyl-Isoglutamine [MeSH concept]
- Mur-NAc-L-Ala-D-isoGln [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1,6-anhydro N-acetylmuramyl-alanyl-glutamyl-diaminopimelic acid [MeSH Supplementary Concept]
- 1,6-anhydromuramyl-alanyl-glutamyl-diaminopimelyl-alanine [MeSH Supplementary Concept]
- 1-(N-acetylmuramyl-alanyl-isoglutaminyl)-2,3-dipalmitoyl-sn-glycerol [MeSH Supplementary Concept]
- 1-O-(acetylmuramyl-alanyl-isoglutaminyl-alanine)-glycerol-3-mycolate [MeSH Supplementary Concept]
- 1-O-(alanyl-isoglutaminyl-alanine)-glycerol-3-mycolate [MeSH Supplementary Concept]
- 2,2'-O-(2,2'-diacetamido-2,3,2',3'-tetradeoxy-6,6'-di-O-(2-tetradecylhexadecanoyl)-alpha,alpha'-trehalose-3,3'-diyl)bis(N-lactoyl-alanyl-isoglutamine) [MeSH Supplementary Concept]
- 6-O-(3-hydroxy-2-docosylhexacosanoyl)muramyl dipeptide [MeSH Supplementary Concept]
- 6-O-stearoyl-N-acetylmuramyl-alanylisoglutamine [MeSH Supplementary Concept]
- 6-O-stearoyl-N-acetylmuramyl-alpha-aminobutyryl-isoglutamine [MeSH Supplementary Concept]
- AcMu-Ala-iso-Gln-meso-2,2'-diaminopimelic acid-Ala-Ala [MeSH Supplementary Concept]
- B 30-muramyl dipeptide [MeSH Supplementary Concept]
- GM 53 [MeSH Supplementary Concept]
- GMTP-N-DPG [MeSH Supplementary Concept]
- LHRH, N-Ac-muramyl-Ala-iso-Glu-LysNH2- [MeSH Supplementary Concept]
- N(2)-(O-benzyl-N-(acetylmuramyl)-alanyl-isoglutaminyl)-N(6)-(3-nitrocinnamoyl)-lysine [MeSH Supplementary Concept]
- N-(2-O-(2-acetamido-1,2,3,5-tetradeoxy-1,5-iminoglucitol-3-yl)lactoyl)alanyl-isoglutamine [MeSH Supplementary Concept]
- N-(2-acetamido-2,3-dideoxyglucopyranos-3-yl)glycyl-alanyl-isoglutamine methyl ester [MeSH Supplementary Concept]
- N-(2-acetamido-2,3-dideoxyglucos-3-yl)glycyl-alanyl-glutamine methyl ester [MeSH Supplementary Concept]
- N-acetyl-6-amino-6-deoxymuramoyl dipeptide [MeSH Supplementary Concept]
- N-acetyl-beta-glucosaminyl-N-acetylmuramyl-alanylisoglutamine [MeSH Supplementary Concept]
- N-acetyl-demethylmuramyl-alanyl-isoglutamine [MeSH Supplementary Concept]
- N-acetyl-nor-muramyl-L-alanyl-D-isoglutamine [MeSH Supplementary Concept]
- N-acetyl-thiomuramyl-alanyl-isoglutamine [MeSH Supplementary Concept]
- N-acetylglucosamine-N-acetylmuramyl-alanyl-isoglutaminyl-alanyl-glycerol dipalmitoyl [MeSH Supplementary Concept]
- N-acetylmuramyl-alanyl-isoglutamine 3'-n-propyl ester [MeSH Supplementary Concept]
- N-acetylmuramyl-alanyl-isoglutamine-alanyl-cholesterol [MeSH Supplementary Concept]
- N-acetylmuramyl-alanyl-isoglutaminyl-(3'-iodo-4'-azidophenylalanine) methyl ester [MeSH Supplementary Concept]
- N-acetylmuramyl-alanyl-isoglutaminyl-lysine [MeSH Supplementary Concept]
- N-acetylmuramyl-alanyl-isoglutamyl-lysine-fluorescein isothiocyanate [MeSH Supplementary Concept]
- N-acetylmuramyl-alanyl-seryl-isoglutamine [MeSH Supplementary Concept]
- N-acetylmuramyl-alanylglutamic acid [MeSH Supplementary Concept]
- N-acetylmuramyl-alanylglutamine methyl ester [MeSH Supplementary Concept]
- N-acetylmuramyl-aminobutyryl-isoglutamine [MeSH Supplementary Concept]
- N-acetylmuramyl-serylisoglutamine [MeSH Supplementary Concept]
- N-acetylmuramyl-threonyl-isoglutamine [MeSH Supplementary Concept]
- N-palmitoylmuramyl-alanyl-isoglutamine [MeSH Supplementary Concept]
- N-trans-2-((2-(acetylamino)cyclohexyl)acetyl)-alanyl-glutamic acid [MeSH Supplementary Concept]
- O-(2-acetamido-2-deoxy-6-O-(2-tetradecylhexadecanoyl)glucopyranosyl)-1-4-N-acetylnormuramoyl-alpha-aminobutanoyl-isoglutamine [MeSH Supplementary Concept]
- O-(2-acetamido-2-deoxy-6-O-stearoylglucopyranosyl)-1-4-N-acetylnormuramoyl-alpha-aminobutanoyl-isoglutamine [MeSH Supplementary Concept]
- SQ 28370 [MeSH Supplementary Concept]
- TLR2-NOD2 agonist CL429 [MeSH Supplementary Concept]
- acetylmuramyl-valylisoglutamine [MeSH Supplementary Concept]
- dimethyl-N-acetylmuramyl-alanylglutamate [MeSH Supplementary Concept]
- disaccharide tetrapeptide [MeSH Supplementary Concept]
- disaccharide tripeptide [MeSH Supplementary Concept]
- epsilon-aminocaproic murabutide [MeSH Supplementary Concept]
- glikopin [MeSH Supplementary Concept]
- glucosaminylmuramyl-2-alanine-D-isoglutamine [MeSH Supplementary Concept]
- mifamurtide [MeSH Supplementary Concept]
- murabutide [MeSH Supplementary Concept]
- muracein A [MeSH Supplementary Concept]
- muracein B [MeSH Supplementary Concept]
- muracein C [MeSH Supplementary Concept]
- muramoyl-alanylisoglutamine [MeSH Supplementary Concept]
- muramylNAc-Ala-isoGln-Lys-tripeptide [MeSH Supplementary Concept]
- mycoloyl-N-acetylmuramyl-alanylisoglutamine [MeSH Supplementary Concept]
- quinonyl-MDP-66 [MeSH Supplementary Concept]
- romurtide [MeSH Supplementary Concept]
- sleep-promoting factor S [MeSH Supplementary Concept]
- syntex adjuvant formulation [MeSH Supplementary Concept]
- technetium tc 99m muramylpolypeptide [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Muramyl Dipeptide [NCIt concept]
- acetylmuramyl-alanyl-isoglutamine [Substance BNPC]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients